GAPDH and glioblastoma: Yuan et al.11 reported that 3-BrOP was able to inhibit two glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and hexokinaseII (HKII), and preferentially killed glioblastoma stem cells (GSCs) that have high glycolytic activity.